Effect of experimental hypoalbuminemia on the plasma protein binding of tolmetin.
The purpose of this work was to study tolmetin plasma protein binding in an experimental model of hypoalbuminemia in the rat. Hypoalbuminemia was produced by repetitive plasmapheresis, achieving a 26.2 +/- 4.6% reduction in albumin circulating levels. Rats then received a 100 mg/kg oral tolmetin dose. Control rats received oral tolmetin 10, 56 or 100 mg/kg. Tolmetin plasma protein binding was determined by an ultrafiltration technique using an in vivo pharmacokinetic approach. Plasma protein binding data for the 3 doses studies in control animals could be described considering a single binding site with Kd = 21.9 +/- 2.1 microM and N = 0.98 +/- 0.05 sites per molecule of albumin. For hypoalbuminemic rats Kd was significantly increased (p < 0.05), while there was no significant change in the number of binding site per albumin molecule (Kd = 131.6 +/- 38.1 microM and N = 1.58 +/- 0.77). Our results show that hypoalbuminemia produces a disproportionate increase in the free fraction of tolmetin, not only by reducing albumin concentration, but also by a decrease in affinity. The mechanism responsible of such changes in affinity remains to be elucidated.
Pérez-Urizar
José
J
Sección Externa de Farmacología, CINVESTAV-IPN, Av. IPN No. 2508. San Pedro Zacatenco, D.F. 07360, México, Mexico. jpurizar@uaslp.mx
Flores-Murrieta
Francisco J
FJ
Castañeda-Hernández
Gilberto
G
D000818:Animals; D011485:Protein Binding; D051381:Rats; D017208:Rats, Wistar; D012709:Serum Albumin / Q000378:metabolism*; D014046:Tolmetin / Q000378:metabolism* / Q000493:pharmacokinetics
D012709:Serum Albumin; D014046:Tolmetin